Tayllit Aherdan is the Vice President and General Manager for Gulf Countries at Eli Lilly, where she leads the company’s business across the United Arab Emirates, Qatar, and Kuwait. Responsible for the full country P&L, she is driving Lilly’s growth strategy across the Gulf while advancing the company’s ambition to be a trusted healthcare partner, accelerating innovation, expanding patient access, and strengthening partnerships across the healthcare ecosystem. Aherdan brings more than 20 years in international biopharmaceutical leadership across North Africa, the Middle East, Asia, Europe and other geographies outside of the United States. She most recently served as Chief Marketing Officer for Lilly China, where she spearheaded the development of industry-leading digital transformation of commercial strategy in one of the world's most competitive healthcare ecosystems. Earlier, as Vice President, International Oncology, she oversaw pre-launch and launch strategies across more than 100 markets spanning Latin America, Europe, the Middle East, Africa, and Asia, including China and Japan, helping accelerate patient access to breakthrough medicines across diverse healthcare systems.